Trial intelligence / Profile preview

Evicel in Total Knee Prosthesis Surgery

NCT00983112Phase 4Unknown

Sponsor
Clinique Mutualiste Chirurgicale de la Loire
Start
Sep 2009
Primary completion
Sep 2012
Modality
Biologic
Countries
1
01

Overview

Phase 4, randomised, single-blind trial in hemorrhage comparing Evicel with Placebo (2 arms). Primary endpoint: Bleeding loss at Day 5. Status: unknown.

02

Drugs

porcine fibrin sealant
03

Conditions

hemorrhage

Beyond the preview

Go deeper on NCT00983112.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00983112.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call